Mar Gonzàlez-Porta

4.8k total citations
10 papers, 769 citations indexed

About

Mar Gonzàlez-Porta is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Mar Gonzàlez-Porta has authored 10 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Infectious Diseases. Recurrent topics in Mar Gonzàlez-Porta's work include RNA Research and Splicing (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Mar Gonzàlez-Porta is often cited by papers focused on RNA Research and Splicing (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Mar Gonzàlez-Porta collaborates with scholars based in United Kingdom, Switzerland and Canada. Mar Gonzàlez-Porta's co-authors include Alvis Brāzma, Johan Rung, Jennifer Harrow, Adam Frankish, Vihandha O. Wickramasinghe, John C. Marioni, Ashok R. Venkitaraman, Jernej Ule, Julien Roux and Sérgio M. Santos and has published in prestigious journals such as Nucleic Acids Research, Nature Biotechnology and Nature Immunology.

In The Last Decade

Mar Gonzàlez-Porta

10 papers receiving 761 citations

Peers

Countries citing papers authored by Mar Gonzàlez-Porta

Since Specialization

Citations

This map shows the geographic impact of Mar Gonzàlez-Porta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Gonzàlez-Porta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Gonzàlez-Porta more than expected).

Fields of papers citing papers by Mar Gonzàlez-Porta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Gonzàlez-Porta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Gonzàlez-Porta. The network helps show where Mar Gonzàlez-Porta may publish in the future.

Co-authorship network of co-authors of Mar Gonzàlez-Porta

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Gonzàlez-Porta. A scholar is included among the top collaborators of Mar Gonzàlez-Porta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Gonzàlez-Porta. Mar Gonzàlez-Porta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Development and validation of a pharmacogenomics reporting workflow based on the illumina global screening array chip 2024 ·Frontiers in Pharmacology ·Pamela Gan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Astrid Irwanto, Ariel Pradipta, (unknown), Mar Gonzàlez-Porta	3
2	Best practices for benchmarking germline small-variant calls in human genomes 2019 ·Nature Biotechnology ·(unknown), Peter Krusche, Len Trigg, Paul C. Boutros, Christopher E. Mason, Francisco M. De La Vega, Benjamin L. Moore, Mar Gonzàlez-Porta, Michael A. Eberle, Živana Težak, Samir Lababidi, Rebecca Truty, George Asimenos, Birgit Funke, Mark Fleharty, Brad Chapman, Marc Salit, Justin M. Zook	182
3	Blood transcriptome profile induced by an efficacious vaccine formulated with salivary antigens from cattle ticks 2019 ·npj Vaccines ·Sandra Regina Maruyama, Benilton S. Carvalho, Mar Gonzàlez-Porta, Johan Rung, Alvis Brāzma, Luiz Gustavo Gardinassi, Beatriz Rossetti Ferreira, (unknown), Cecı́lia José Verı́ssimo, Luciana Morita Katiki, Isabel Kinney Ferreira de Miranda Santos	9
4	Aberration hubs in protein interaction networks highlight actionable targets in cancer 2018 ·Oncotarget ·Mehran Karimzadeh, Pouria Jandaghi, Andreas I. Papadakis, (unknown), Johan Rung, Mar Gonzàlez-Porta, Ghislaine Scélo, Naveen Vasudev, Alvis Brāzma, Sidong Huang, Rosamonde E. Banks, Mark Lathrop, Hamed S. Najafabadi, Yasser Riazalhosseini	2
5	Impact of Alternative Splicing on the Human Proteome 2017 ·Cell Reports ·Yansheng Liu, Mar Gonzàlez-Porta, Sérgio M. Santos, Alvis Brāzma, John C. Marioni, Ruedi Aebersold, Ashok R. Venkitaraman, Vihandha O. Wickramasinghe	116
6	Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5′ splice site strength 2015 ·Genome biology ·Vihandha O. Wickramasinghe, Mar Gonzàlez-Porta, David Perera, Arthur R. Bartolozzi, Christopher R. Sibley, Martina Hallegger, Jernej Ule, John C. Marioni, Ashok R. Venkitaraman	71
7	The RNA-binding protein HuR is essential for the B cell antibody response 2015 ·Nature Immunology ·Manuel D. Díaz‐Muñoz, Sarah E. Bell, Kirsten A. Fairfax, Elisa Monzón‐Casanova, Adam F. Cunningham, Mar Gonzàlez-Porta, Simon Andrews, Victoria I. Bunik, Kathi Zarnack, Tomaž Curk, Ward Heggermont, Stéphane Heymans, Gary E. Gibson, Dimitris L. Kontoyiannis, Jernej Ule, Martin Turner	123
8	Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per gene 2013 ·Genome biology ·Mar Gonzàlez-Porta, Adam Frankish, Johan Rung, Jennifer Harrow, Alvis Brāzma	176
9	Comparative analysis of human and mouse expression data illuminates tissue-specific evolutionary patterns of miRNAs 2012 ·Nucleic Acids Research ·Julien Roux, Mar Gonzàlez-Porta, Marc Robinson‐Rechavi	46
10	Estimation of alternative splicing variability in human populations 2011 ·Genome Research ·Mar Gonzàlez-Porta, Miquel Calvo, Michael Sammeth, Roderic Guigó	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact